#merk #fda #dna

Dr David Wiseman's background is in pharmacology. He asks a reasonable question: How qualified are the FDA to investigate a biologic transfectant when most of the "scientists" don't know what a 3'UTR is, or what pseudouridine does.

Malone doesn't like it.

@auraxchan
#safe #fda #rna #dna